Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

26 Nov 2025 · Review of the EU General Pharmaceutical Legislation

Meeting with Olivér Várhelyi (Commissioner) and Richter Gedeon Nyrt.

15 Oct 2025 · Competitiveness of EU generic pharma industry

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

14 Oct 2025 · Pharmaceutical legislation

Response to General revision of Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in application of Articles 107 and 108 of the Treaty (‘General Block Exemption Regulation’)

6 Oct 2025

Meeting with Olga Solomon (Head of Unit Health and Food Safety) and 10 other interest representatives

3 Oct 2025 · The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.

Meeting with Ondřej Knotek (Member of the European Parliament, Shadow rapporteur)

16 Sept 2025 · To discuss Critical Medicines Act

Meeting with Ingeborg Ter Laak (Member of the European Parliament)

16 Sept 2025 · Critical Medicines Act

Response to Commission Communication on a EU Cardiovascular Health Plan

15 Sept 2025

Meeting with Paul Speight (Head of Unit Environment)

15 Sept 2025 · REACH and Universal PFAS restriction

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

10 Sept 2025 · Revision of the EU Pharmaceutical Directive

Meeting with Aurelijus Veryga (Member of the European Parliament)

10 Sept 2025 · Shaping the Future of EU Pharmaceutical Legislation

Meeting with Sebastian Everding (Member of the European Parliament)

4 Sept 2025 · Critical Medicine Act Report

Meeting with Oliver Schenk (Member of the European Parliament, Rapporteur for opinion)

3 Sept 2025 · European Health Policy - Critical Medicines Act

Meeting with Dan-Ştefan Motreanu (Member of the European Parliament)

3 Sept 2025 · Critical Medicines Act / generic, biosimilar and value added medicines

Meeting with Margarita De La Pisa Carrión (Member of the European Parliament)

2 Sept 2025 · Pharma Package

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

2 Sept 2025 · Critical Medicines Act

Meeting with Pierre Jouvet (Member of the European Parliament)

24 Jul 2025 · critical medicines

Meeting with Viktória Ferenc (Member of the European Parliament)

8 Jul 2025 · Exchange of views on Critical Medicines Act

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

4 Jul 2025 · Pharma Package

Meeting with Patricia Reilly (Cabinet of President Ursula von der Leyen)

26 Jun 2025 · to follow

Meeting with Mohammed Chahim (Member of the European Parliament, Shadow rapporteur for opinion) and 14 other interest representatives

25 Jun 2025 · Roundtable Critical Medicines Act

Meeting with Oliver Schenk (Member of the European Parliament)

25 Jun 2025 · Resilient Health Union

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

19 Jun 2025 · Pharmaceutical package

Meeting with Barry Cowen (Member of the European Parliament, Shadow rapporteur)

17 Jun 2025 · Meeting with Medicines for Europe

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and 10 other interest representatives

13 Jun 2025 · Critical Medicines Act

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Ruggero Razza (Member of the European Parliament) and MUST Partners

11 Jun 2025 · Incontro con gli amministratori locali siciliani

Meeting with Florika Fink-Hooijer (Director-General Health Emergency Preparedness and Response Authority) and Laboratorios Farmacéuticos Rovi, S.A.

2 Jun 2025 · Breakfast on the margins of HERA Industry Days

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Strategy to support medical countermeasures against public health threats

9 May 2025

Response to Communication on the EU Stockpiling Strategy

9 May 2025

Meeting with Ondřej Knotek (Member of the European Parliament)

6 May 2025 · Urban Waste Water Directive

Meeting with Aurelijus Veryga (Member of the European Parliament)

6 May 2025 · Implications of environmental policy on pharmaceutical access

Meeting with Ruggero Razza (Member of the European Parliament) and European Federation of Salaried Doctors

6 May 2025 · Scambio di opinioni in materia di Salute

Meeting with Olivér Várhelyi (Commissioner) and 3 other attendees

30 Apr 2025 · Exchange of views on the EU pharma policy

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Tomislav Sokol (Member of the European Parliament)

1 Apr 2025 · Health policy

Meeting with Dolors Montserrat (Member of the European Parliament)

28 Mar 2025 · Urban Waste Water Treatment Directive

Meeting with Marta Temido (Member of the European Parliament)

25 Mar 2025 · Critical Medicines Act

Response to Targeted evaluation of Regulation (EU)2017/745 on Medical Devices and Regulation (EU)2017/746 on In Vitro Diagnostics

21 Mar 2025

Meeting with Christian Doleschal (Member of the European Parliament, Shadow rapporteur)

20 Mar 2025 · Revision der Vergaberichtlinien

Meeting with Piotr Müller (Member of the European Parliament, Rapporteur)

20 Mar 2025 · Evaluation of the Public Procurement Directives

Meeting with Olivier Chastel (Member of the European Parliament)

14 Mar 2025 · Politique de santé de l'Union européenne

Meeting with Pierre Jouvet (Member of the European Parliament, Shadow rapporteur)

13 Mar 2025 · marchés publics

Meeting with Ruggero Razza (Member of the European Parliament)

11 Mar 2025 · Incontro su CMA - draft report

Response to Evaluation of Directive 2014/23/EU on the award of concessions contracts, Directive 2014/24/EU on public procurement, and Directive 2014/25/EU on procurement by entities operating in the water, energy, transport and postal services sectors

6 Mar 2025

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

4 Mar 2025 · • Critical Medicines Act • Urban Wastewater Treatment Directive

Meeting with Gabriela Tschirkova (Cabinet of Commissioner Valdis Dombrovskis)

3 Mar 2025 · Urban Waste Water Treatment Directive

Meeting with Ulla Schwager (Head of Unit Competition)

3 Mar 2025 · Exchange of views on the future Critical Medicines Act

Response to European Water Resilience Strategy

28 Feb 2025

Response to Critical Medicines Act

26 Feb 2025

Meeting with Ulla Schwager (Head of Unit Competition)

25 Feb 2025 · Exchange of views on Pharma & IP Legislation Reform & possible anti-competitive practices in the pharmaceutical sector

Meeting with Olga Solomon (Head of Unit Health and Food Safety)

20 Feb 2025 · Preparation of participation of Olga Solomon in the Medicines for Europe Regulatory and Scientific Affairs Conference. Exchange of views on the reform of the General Pharmaceutical Legislation.

Response to Single Market Strategy 2025

31 Jan 2025

Meeting with Olivér Várhelyi (Commissioner) and 2 other attendees

29 Jan 2025 · Exchange of views on EU health policy

Meeting with Oliver Schenk (Member of the European Parliament)

28 Jan 2025 · European Health Union

Meeting with Vlad Vasile-Voiculescu (Member of the European Parliament)

28 Jan 2025 · Introductory Meeting

Meeting with Tomislav Sokol (Member of the European Parliament) and 3 other interest representatives

28 Jan 2025 · Health Policy

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

17 Dec 2024 · critical medicines act

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

26 Nov 2024 · Pharmaceutical policy

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

24 Oct 2024 · New EU Pharmaceutical Legislation

Meeting with Dan-Ştefan Motreanu (Member of the European Parliament)

16 Oct 2024 · EU pharmaceutical reform

Meeting with Tomislav Sokol (Member of the European Parliament) and EUROPEAN ORGANISATION FOR RARE DISEASES

17 Sept 2024 · Health policy

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council as regards the format of the labels for certain products and equipment containing fluorinated greenhouse gases and repealing Commission Implementing Regulation (EU) 2015/2068

3 Jun 2024

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

18 Apr 2024 · Supplementary protection certificates

Response to Ex post evaluation of the EU-Canada Comprehensive Economic and Trade Agreement (CETA), after five years of provisional application of the agreement.

12 Apr 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL establishing a common data platform on chemicals, laying down rules to ensure that the data contained in it are findable, accessible, interoperable and reusable and establishing a monitoring and outlook framework for chemicals

14 Mar 2024

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

29 Feb 2024

Meeting with Dolors Montserrat (Member of the European Parliament)

16 Feb 2024 · Revision of the pharmaceutical legislation

Meeting with Adam Jarubas (Member of the European Parliament) and 4 other interest representatives

31 Jan 2024 · EU pharmaceutical roundtable - the EU institutions’ representatives and the stakeholder's dialogue

Meeting with Nicola Danti (Member of the European Parliament)

25 Jan 2024 · Revisione pacchetto farmaceutico

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and 2 other interest representatives

22 Jan 2024 · Directive on Medicinal products for human use

Meeting with Aldo Patriciello (Member of the European Parliament)

29 Nov 2023 · Pharma strategy

Meeting with Laura Ballarín Cereza (Member of the European Parliament, Shadow rapporteur for opinion)

13 Nov 2023 · Pharmaceutical Package (Regulation)

Meeting with Adrián Vázquez Lázara (Member of the European Parliament, Shadow rapporteur)

8 Nov 2023 · Unitary SPC

Meeting with Deirdre Clune (Member of the European Parliament) and Novartis International AG

7 Nov 2023 · Pharmaceutical Package

Meeting with Dolors Montserrat (Member of the European Parliament) and Novartis International AG

6 Nov 2023 · Revision of the pharmaceutical legislation

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

27 Oct 2023 · discussion on the General Pharmaceutical Package revision

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

27 Oct 2023 · Pharmaceutical Package

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and GSK

27 Oct 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament)

25 Oct 2023 · Pharma Revision (staff level)

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

25 Oct 2023 · Medicines

Meeting with Tiemo Wölken (Member of the European Parliament) and 2 other interest representatives

18 Oct 2023 · Pharma Revision - Directive (staff level)

Meeting with Mohammed Chahim (Member of the European Parliament)

16 Oct 2023 · Pharmaceutical Strategy

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

6 Oct 2023 · SPC Medicinal Products (staff level)

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

5 Oct 2023 · Meeting with Medicines for Europe on tackling medicines shortages.

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

4 Oct 2023 · Pharmaceutical package

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

29 Sept 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

29 Sept 2023

Meeting with Catherine Amalric (Member of the European Parliament, Shadow rapporteur)

27 Sept 2023 · Reform of the EU pharmaceutical legislation

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

26 Sept 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the supplementary protection certificate for plant protection products (recast)

18 Sept 2023

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Bundesverband der Pharmazeutischen Industrie e.V.

6 Sept 2023 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

31 Jul 2023 · Revision of the Pharmaceutical Legislation (staff level)

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on compulsory licensing for crisis management and amending Regulation (EC) 816/2006

28 Jul 2023

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

18 Jul 2023 · Pharmaceutical legislation

Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)

14 Jul 2023 · Pharma legislation

Meeting with Daphne Von Buxhoeveden (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

13 Jul 2023 · Meeting with Medicines for Europe on critical medicines

Meeting with Beatrice Covassi (Member of the European Parliament)

5 Jul 2023 · Drug accessibility and European health industrial policy

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

7 Jun 2023 · Unitary SPC - SPC Revision (staff level)

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

7 Jun 2023 · Medicines Security Act

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur) and 3 other interest representatives

7 Jun 2023 · Medicines

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

6 Jun 2023 · Revision of Pharmaceutical Legislation (staff level)

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use

16 May 2023

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

15 May 2023 · Medicines

Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)

2 May 2023 · Pharma legislation

Meeting with Pietro Fiocchi (Member of the European Parliament, Shadow rapporteur)

19 Apr 2023 · Packaging and packaging waste, amending Regulation (EU) 2019/1020 and Directive (EU) 2019/904, and repealing Directive 94/62/EC

Meeting with Tiemo Wölken (Member of the European Parliament) and GSK

3 Apr 2023 · EU-Health Policy (staff level)

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

20 Mar 2023 · Upcoming pharmaceutical legislation

Meeting with Peter Van Kemseke (Cabinet of President Ursula von der Leyen)

20 Mar 2023 · Pharma legislation

Meeting with Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

17 Mar 2023 · Revision of the Pharmaceutical legislation

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 2000/60/EC establishing a framework for Community action in the field of water policy, Directive 2006/118/EC on the protection of groundwater against pollution and deterioration and Directive 2008/105/EC on environmental quality standards in the field of water policy

14 Mar 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL concerning urban wastewater treatment (recast)

14 Mar 2023

Meeting with Cristian-Silviu Buşoi (Member of the European Parliament, Rapporteur)

8 Mar 2023 · EMA Fees Regulation

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fees and charges payable to the European Medicines Agency, amending Regulation (EU) 2017/745 of the European Parliament and of the Council and repealing Council Regulation (EC) No 297/95 and Regulation (EU) 658/2014 of the European Parliament and of the Council

7 Feb 2023

Meeting with Dolors Montserrat (Member of the European Parliament, Rapporteur)

8 Dec 2022 · Lessons learned on impact of COVID-19 pandemic

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

10 Nov 2022 · will follow

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

10 Nov 2022 · EU strategic autonomy for the production of active pharmaceutical ingredients

Meeting with Despina Spanou (Cabinet of Vice-President Margaritis Schinas), Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

9 Nov 2022 · Pharma strategy

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

9 Nov 2022 · Exchange of views on the pharma reform

Response to Commission Communication on the EU Strategic Framework for Global Health

16 Sept 2022

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) No 952/2013 of the European Parliament and of the Council of 9 October 2013 laying down the Union Customs Code

14 Sept 2022

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

30 Jun 2022 · Pharma strategy

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur) and Biogen

30 Jun 2022 · Generics

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

27 Jun 2022 · Health industrial ecosystem and supply chains

Meeting with Nicolás González Casares (Member of the European Parliament, Shadow rapporteur)

12 May 2022 · Generics

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

12 May 2022 · Exchange of views on the upcoming pharmaceutical strategy.

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EU) No 658/2014 of the European Parliament and of the Council as regards the adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use

28 Apr 2022

Response to Enhancing the coherence and effectiveness of compulsory licensing of patents in the EU, especially in crisis situations, including for export purposes to third countries

27 Apr 2022

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

26 Apr 2022 · Pharma Strategy

Meeting with Stella Kyriakides (Commissioner) and 1 other attendee

26 Apr 2022 · Meeting with representatives of Medicines for Europe

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

24 Apr 2022 · Supply security & production capacity for critical medicines and ingredients

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

4 Apr 2022

Response to Commission proposal for a Council Recommendation on strengthened One Health Actions against Antimicrobial Resistance

23 Mar 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EU) No 536/2014 as regards a derogation from certain obligations concerning investigational medicinal products made available in the United Kingdom with respect to Northern Ireland as well as in Cyprus, Ireland and Malta

15 Mar 2022

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of Northern Ireland, as well as in Cyprus, Ireland and Malta

15 Mar 2022

Meeting with Sandra Gallina (Director-General Health and Food Safety)

21 Jan 2022 · Exchange of views on the role of the generic and bio-similar industry under the EU pharmaceutical strategy.

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

26 Oct 2021 · Exchange of views on the upcoming revision of the pharmaceutical legislation and the Health Union

Meeting with Margaritis Schinas (Vice-President) and 1 other attendee

8 Oct 2021 · Pharma Strategy

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards the European Database on Medical Devices (Eudamed)

21 Jun 2021

Meeting with Margaritis Schinas (Vice-President) and 15 other attendees

16 Jun 2021 · Supply chains for medicines

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

7 Jun 2021 · VTC meeting - Access to Medicines

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

22 Apr 2021

Meeting with Salvatore De Meo (Member of the European Parliament)

19 Apr 2021 · Various

Meeting with Stella Kyriakides (Commissioner) and 2 other interest representatives

5 Mar 2021 · VC Meeting discussion on COVID-19 vaccines export authorisation scheme.

Response to Proposal for a Regulation of the European Parliament and of the Council establishing a European Health Emergency Response Authority (HERA)

24 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on serious cross-border threats to health and repealing Decision No 1082/2013/EU

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

2 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices

2 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

21 Dec 2020

Meeting with Kim Jorgensen (Cabinet of Executive Vice-President Margrethe Vestager)

13 Nov 2020 · Upcoming Pharmaceutical strategy, links to digital technologies, data and competition.

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

6 Nov 2020 · Covid-19

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

6 Nov 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Kurt Vandenberghe (Cabinet of President Ursula von der Leyen)

6 Nov 2020 · COVID-19

Response to Ex post evaluation of the economic adjustment programmes for Greece (2010-2018).

29 Oct 2020

Meeting with Maria Luisa Llano Cardenal (Cabinet of Vice-President Margaritis Schinas)

27 Oct 2020 · Pharma Strategy

Meeting with Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

27 Oct 2020 · Medicines for Europe - Exchange of views on the upcoming Pharmaceutical Strategy.

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides) and European Federation of Pharmaceutical Industries and Associations

22 Oct 2020 · Exchange of views on the upcoming pharmaceutical strategy

Meeting with Thierry Breton (Commissioner) and 2 other attendees

20 Oct 2020 · Production capacity of generic medicines in the EU

Meeting with Stella Kyriakides (Commissioner) and 12 other attendees

30 Sept 2020 · Call with pharmaceutical and medical device supply Chain on COVID-19

Meeting with Stella Kyriakides (Commissioner)

17 Jul 2020 · Exchange of views on the upcoming Pharmaceutical Strategy

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

29 Jun 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and 9 other attendees

29 Jun 2020 · Call with pharmaceutical and medical device industry associations on COVID-19

Meeting with Stella Kyriakides (Commissioner) and 8 other interest representatives

29 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

15 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

8 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 6 other interest representatives

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 6 other interest representatives

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

17 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 7 other interest representatives

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 5 other interest representatives

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

3 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 5 other interest representatives

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 5 other interest representatives

27 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and 4 other interest representatives

20 Mar 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

20 Mar 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and 4 other interest representatives

13 Mar 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak

Response to Proposal for an EP and Council Regulation on fees charged by the European Medicines Agency (EMA), including remuneration paid to National Competent Authorities (NCAs), for activities related to obtaining and maintaining marketing authorisations for medicinal products for human and veterinary use.

16 Oct 2019

Meeting with Timo Pesonen (Acting Director-General Internal Market, Industry, Entrepreneurship and SMEs)

15 Jul 2019 · Introduce themselves and present the manufacturers of generic medicines general position for the future Commission

Meeting with Anne Bucher (Director-General Health and Food Safety)

5 Jun 2019 · Next European Commission holistic strategy for access to off patent medicines; future of pharmaceutical policies; regulatory optimisation; biosimilar medicines; international convergence

Meeting with Jean-Luc Demarty (Director-General Trade)

7 May 2019 · EU-US issues, EU trade agreements, FTAs

Meeting with Paulina Dejmek Hack (Cabinet of President Jean-Claude Juncker)

11 Feb 2019 · Supplementary Protection certificate (SPC)

Meeting with Jyrki Katainen (Vice-President)

11 Feb 2019 · SPC manufacturing waiver

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

4 Feb 2019 · Supplementary Protection Certificates

Meeting with Paulina Dejmek Hack (Cabinet of President Jean-Claude Juncker)

20 Nov 2018 · Commission's proposal on a Supplementary Protection Certificate

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

25 Oct 2018 · Supplementary protection certificate

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

17 Jul 2018 · Supplementary protection certificate, pharmaceuticals in the environment, AMR

Meeting with Vytenis Andriukaitis (Commissioner) and 10 other attendees

15 Jun 2018 · HTA

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

10 Apr 2018 · SPC

Meeting with Fabrice Comptour (Cabinet of Commissioner Elżbieta Bieńkowska), Tomasz Husak (Cabinet of Commissioner Elżbieta Bieńkowska)

8 Feb 2018 · SPC

Meeting with Nele Eichhorn (Cabinet of Vice-President Cecilia Malmström)

30 Jan 2018 · Supplementary Protection Certificate Manufacturing Waiver

Meeting with Fabrice Comptour (Cabinet of Commissioner Elżbieta Bieńkowska)

9 Jan 2018 · SPC manufacturing waiver

Meeting with Jyrki Katainen (Vice-President)

21 Nov 2017 · Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC)

Meeting with Filomena Chirico (Cabinet of Vice-President Jyrki Katainen)

23 Nov 2016 · IPR actions in the single market strategy

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

20 Oct 2016 · Follow-up to Council conclusions, AMR

Meeting with Xavier Prats Monné (Director-General Health and Food Safety)

5 Jul 2016 · Discuss the next Commission Action Plan on antimicrobial resistance (AMR)

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

20 Jun 2016 · Biosimilars

Meeting with Marika Lautso-Mousnier (Cabinet of Vice-President Jyrki Katainen)

13 Apr 2016 · IP and pharmaceuticals in the EC Single Market Strategy, SPC Manufacturing Waiver proposal

Meeting with Xavier Prats Monné (Director-General Health and Food Safety)

10 Dec 2015 · European healthcare policies

Meeting with Cecile Billaux (Cabinet of Vice-President Cecilia Malmström)

16 Oct 2015 · Internal Market strategy

Meeting with Elżbieta Bieńkowska (Commissioner) and 1 other attendee

11 May 2015 · Introductory meeting

Meeting with Elżbieta Bieńkowska (Commissioner)

11 May 2015 · Meeting with Beata Stępniewska (EGA Deputy Director General )

Meeting with Clara Martinez Alberola (Cabinet of President Jean-Claude Juncker)

24 Mar 2015 · European Union’s policies affecting the pharmaceutical sector

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

6 Mar 2015 · Intro meeting

Meeting with Eveline Lecoq (Cabinet of Commissioner Carlos Moedas)

26 Feb 2015 · Generic medicines and biosimilars

Meeting with Aura Salla (Cabinet of Vice-President Jyrki Katainen)

18 Feb 2015 · Pharmaceutical Industry

Meeting with Vytenis Andriukaitis (Commissioner) and 1 other attendee

4 Feb 2015 · EGA manifesto

Meeting with Ladislav Miko (acting Director-General Health and Food Safety)

20 Jan 2015 · Exchange of views regarding the EU strategic plan for 2015-2016 and EGA vision

Meeting with Nathalie Chaze (Cabinet of Commissioner Vytenis Andriukaitis)

18 Dec 2014 · Pharma policy coordination; European semester process; COM 2015 workplan for pharmaceuticals.

Meeting with Cecile Billaux (Cabinet of Vice-President Cecilia Malmström)

10 Dec 2014 · Presentation of the association